Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | PGK1 | P00558 | 1/20 | 0.36 |
| ▸ | PGK2 | P07205 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6512553 | 0.80 | TSHR (0.50) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL10890440 | 0.76 | NR1H2 (0.54) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL16586837 | 0.76 | TSHR (0.46) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL17288747 | 0.75 | TSHR (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL160204 | 0.75 | TSHR (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL8582066 | 0.75 | TSHR (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL146900 | 0.75 | TSHR (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL951559 | 0.75 | TSHR (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL612731 | 0.75 | ALDH1A1 (0.58) | TSHRALDH1A1PTPN1KCNN4CA1 | |
| SCHEMBL1483475 | 0.75 | TSHR (0.44) | TSHRALDH1A1PTPN1KCNN4CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12403159-B2 | Therapeutic metal complexes and ligands and methods of making and using the same | OREGON STATE UNIVERSITY (US) | 2025-09-02 | — | — | US | claimed |
| US-11596651-B2 | Therapeutic metal complexes and ligands and methods of making and using the same | OREGON STATE UNIVERSITY (US) | 2023-03-07 | — | — | US | claimed |
| US-12403159-B2 | Therapeutic metal complexes and ligands and methods of making and using the same | OREGON STATE UNIVERSITY (US) | 2025-09-02 | — | — | US | disclosed |
| US-20230172977-A1 | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2023-06-08 | — | — | US | disclosed |
| US-11596651-B2 | Therapeutic metal complexes and ligands and methods of making and using the same | OREGON STATE UNIVERSITY (US) | 2023-03-07 | — | — | US | disclosed |
| US-4147884-A | Liquid phase oxidation of unsaturated aldehydes to corresponding acids | ATLANTIC RICHFIELD COMPANY (US) | 1979-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172977-A1 | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME | TUFM, SMN1; SMN2, MCU | TSHR 3811/4885ALDH1A1 293/4885PTPN1 4078/4885 |
| US-12403159-B2 | Therapeutic metal complexes and ligands and methods of making and using the same | TUFM, SMN1; SMN2, MCU | TSHR 3811/4885ALDH1A1 293/4885PTPN1 4078/4885 |
| US-11596651-B2 | Therapeutic metal complexes and ligands and methods of making and using the same | TUFM, SMN1; SMN2, MCU | TSHR 3811/4885ALDH1A1 293/4885PTPN1 4078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.